CROSSJECT (EPA:ALCJ) | WebDisclosure

Basculer en Français

11144	Companies
245599	Keywords
173662	Articles
132540	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 06/26/2024 at 07:30, 2 years 3 months ago

Crossject met en perspective le potentiel de ZEPIZURE® à la lumière de l'étude de référence RAMPART et de sa propre étude de bioéquivalence récemment publiée.
Crossject met en perspective le potentiel de ZEPIZURE® à la lumière des études RAMPART et de bioéquivalence. Analyse des avantages de l'injection IM de midazolam dans la prise en charge des crises d'épilepsie

Crossject ZEPIZURE RAMPART Étude De Bioéquivalence Injection IM
PRESS RELEASE

published on 06/26/2024 at 07:30, 2 years 3 months ago

Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study
Crossject provides insights on ZEPIZURE® potential in light of RAMPART and its bioequivalence study. IM midazolam favored over IV lorazepam for emergency epilepsy management

Crossject ZEPIZURE RAMPART Study Bioequivalence Study Emergency Epilepsy Management
BRIEF

published on 06/18/2024 at 12:35, 2 years 3 months ago

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Droits De Vote Capital Social AMF Pharmacie Spécialisée Crossject
BRIEF

published on 06/18/2024 at 12:35, 2 years 3 months ago

Crossject: Information relating to the total number of voting rights and shares making up the share capital

Share Capital Voting Rights AMF Crossject Specialized Pharmacy
PRESS RELEASE

published on 06/18/2024 at 12:30, 2 years 3 months ago

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
Publication du nombre total de droits de vote et d'actions de CROSSJECT au 31 mai 2024 conformément aux réglementations. Détails sur le capital social

Droits De Vote Capital Social AMF Crossject Pharma
BRIEF

published on 06/13/2024 at 09:41, 2 years 3 months ago

Crossject : Information sur le nombre de droits de vote et d'actions

Droits De Vote Capital Social Actions 2024 Crossject
BRIEF

published on 06/13/2024 at 09:41, 2 years 3 months ago

Crossject: Information on the number of voting rights and shares

Share Capital Voting Rights Actions 2024 Crossject
PRESS RELEASE

published on 06/13/2024 at 09:36, 2 years 3 months ago

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
Crossject publie le nombre total de droits de vote et d'actions au 31 mai 2024 conformément aux normes réglementaires

Droits De Vote Capital Social Actions Crossject Pharma
BRIEF

published on 06/12/2024 at 07:35, 2 years 3 months ago

Crossject nomme Dan Chiche, MD au poste de Directeur Médical Amérique du Nord

Crossject ZEPIZURE® Dan Chiche Directeur Médical
BRIEF

published on 06/12/2024 at 07:35, 2 years 3 months ago

Crossject Appoints Dan Chiche, MD as North America Chief Medical Officer

Crossject ZEPIZURE® Dan Chiche Medical Director

Accesswire

Published on 10/07/2026 at 17:00, 2 hours 27 minutes ago

BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 3 hours 57 minutes ago

Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 4 hours 57 minutes ago

Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance
Published on 10/07/2026 at 13:33, 5 hours 54 minutes ago

BULGOLD Samples 21.2g/t Gold at Surface and Expands Kopernica Footprint by 170% to 1,700 Metres by 800 Metres, Lutila Project
Published on 10/07/2026 at 13:00, 6 hours 27 minutes ago

ATHA Energy Successfully Completes Diamond Drilling at RIB North Discovery, Expanding Strike Length To 3.4 Km, And Identifies a Higher-Grade Sub Zone: Results Include RIBN-DD-023 Intersecting 19.5 M Of Composite Uranium Mineralization With 2.0 M Of High-G

View all ACCESSWIRE

EQS Group

Published on 10/07/2026 at 18:30, 57 minutes ago

IEVA GROUP: rappel – Visioconference actionnaires et investisseurs jeudi 15 octobre 2026 - 18h00 (CEST)
Published on 10/07/2026 at 18:15, 1 hour 12 minutes ago

VAZIVA SA: 2026 HALF-YEAR RESULTS - A half-year of strategic investments to prepare a new growth cycle
Published on 10/07/2026 at 18:00, 1 hour 27 minutes ago

EUROPLASMA: Réduction de capital et regroupement des actions Europlasma
Published on 10/07/2026 at 17:44, 1 hour 43 minutes ago

BILENDI: Half-year 2026 Results: Continued execution of the strategic plan in a challenging market environment
Published on 10/07/2026 at 17:44, 1 hour 43 minutes ago

BILENDI: Résultats semestriels 2026 : Poursuite de l’exécution du plan stratégique dans un environnement de marché exigeant

Les Echos

Published on 10/07/2026 at 18:19, 1 hour 7 minutes ago

Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 18:19, 1 hour 7 minutes ago

Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 30 septembre 2026
Published on 10/07/2026 at 18:00, 1 hour 27 minutes ago

Mint organise une visioconférence pour annoncer ses résultats semestriels 2026.
Published on 10/07/2026 at 18:00, 1 hour 27 minutes ago

Cegedim Assurances et Shift Technology fêtent 5 ans de partenariat et intègrent WTW au sein de leur dispositif commun de lutte contre la fraude
Published on 10/07/2026 at 18:00, 1 hour 27 minutes ago

LDC : Chiffre d’affaires du 1er semestre 2026-2027.

View all LES ECHOS COMFI WIRE